Financials
Financial year 2025
BIOTECH-INVEST from Lievegem, company number BE0476881001, closed financial year 2025 with a result of € 203,964 after tax. For that financial year BIOTECH-INVEST recorded a gross margin of € 348,432 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 89,998 to € 203,964. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ 1.7 million
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 203,964
▲ 127% vs 2024
Profit after tax over the fiscal year.
€ 780,819
▼ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.2 million.
People and assets in 2025
€ 22,531
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9,522
▲ € 8,022 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 46,324
▲ € 35,275 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 219,758 | € 230,737 | € 209,570 | € 348,432 | ▲ 66% |
| Profit after taxes | € 354,979 | € 96,085 | € 89,998 | € 203,964 | ▲ 127% |
| Equity | € 1,451,801 | € 1,547,886 | € 1,543,569 | € 1,747,533 | ▲ 13% |
| Total debts | € 810,864 | € 829,222 | € 934,926 | € 465,277 | ▼ 50% |
| Cash | € 941,719 | € 1,371,197 | € 1,029,288 | € 780,819 | ▼ 24% |
| Land & buildings | € 709,221 | € 685,886 | € 667,357 | € 648,827 | ▼ 3% |
| Retained profit | € 917,501 | € 1,013,586 | € 1,009,269 | € 1,213,233 | ▲ 20% |
| Dividend | € 336,102 | € 0 | € 94,314 | € 0 | ▼ 100% |
| Balance sheet total | € 2,262,665 | € 2,377,108 | € 2,478,496 | € 2,212,810 | ▼ 11% |
Key figures of BIOTECH-INVEST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to BIOTECH-INVEST?
What happened at BIOTECH-INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 203,964 (▲ 127% vs 2024). Source: NBB ↗
- New establishment in Lievegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 354,979 profit in 2022 to € 203,964 profit in 2025.
Paid € 249,289 in corporate taxes since 2022.
Best year ever: 2022, with € 354,979 profit.
Paid out € 430,416 in dividends to the owners in total.
Management
Behind BIOTECH-INVEST are Kathleen LAMMENS and Stefaan Fernand HEYVAERTS. It owns 75% of BIOTECH-ENGINEERING BVBA itself.
Directors
According to the 2025 annual accounts
Kathleen LAMMENS
Director
Stefaan Fernand HEYVAERTS
Director
Establishments
Establishment units
Physical locations of this company
Brugstraat 48
9921 Lievegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0476.881.001
- VAT number
- BE 0476.881.001
- Registered office
- Brugstraat 48, 9921 Lievegem
- Names & denominations
- BIOTECH-INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 February 2002
- Peppol
- Active · Active since 17 Jun 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Managementactiviteiten van holdings
Adviesbureaus op het gebied van public relations en communicatie
Activiteiten van holdings
Public relationsbureaus
Holdings